Cargando…
Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis
Rebleeding following endoscopic treatment in patients with cirrhosis is a serious life-threatening complication. In the present study, a novel, reliable and non-invasive score for prediction of rebleeding following endoscopic therapy for esophagogastric variceal bleeding (EGVB) was developed. The pr...
Autores principales: | Li, Fenghui, Wang, Tao, Liang, Jing, Qian, Baoxin, Tang, Fei, Gao, Yanying, Lv, Jiayu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562956/ https://www.ncbi.nlm.nih.gov/pubmed/37822588 http://dx.doi.org/10.3892/etm.2023.12200 |
Ejemplares similares
-
Associations Between Endoscopic Primary Prophylaxis and Rebleeding in Liver Cirrhosis Patients with Esophagogastric Variceal Bleeding
por: Gao, Yanying, et al.
Publicado: (2022) -
Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
por: Zhang, Qun, et al.
Publicado: (2020) -
Analysis of the timing of endoscopic treatment for esophagogastric variceal bleeding in cirrhosis
por: Wu, Kaini, et al.
Publicado: (2022) -
Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis
por: Mohammed, Sara Elfadil Abbas, et al.
Publicado: (2016) -
Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis
por: Pfisterer, Nikolaus, et al.
Publicado: (2021)